Publication | Closed Access

Discovery of Kibdelomycin, A Potent New Class of Bacterial Type II Topoisomerase Inhibitor by Chemical-Genetic Profiling in Staphylococcus aureus

Antimicrobial SusceptibilityChemical-genetic ProfilingMedicineAntibiotic AdjuvantStaphylococcus AureusAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundAntibiotic ResistancePharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance